Kiniksa Pharmaceuticals (KNSA)
(Real Time Quote from BATS)
$25.20 USD
-0.52 (-2.02%)
Updated Aug 14, 2024 02:46 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/29/2024
Time: -- |
9/2024 | $-0.01 | 0.00% |
Earnings Summary
For their last quarter, Kiniksa Pharmaceuticals (KNSA) reported earnings of -$0.06 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 33.33%. Look out for KNSA's next earnings release expected on October 29, 2024. For the next earning release, we expect the company to report earnings of -$0.01 per share, reflecting a year-over-year increase of 95%.
Earnings History
Price & Consensus
Zacks News for KNSA
Zacks.com featured highlights include Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp
KNSA: What are Zacks experts saying now?
Zacks Private Portfolio Services